Stockreport

Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Compass Therapeutics, Inc.  (CMPX) 
PDF BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprieta [Read more]